Webinar: Screening Immunotoxicity of T Cell Engagers and Biologics Using NAMs

At Alcyomics, we are bringing together scientists, industry experts, and innovators for a new webinar series exploring how advanced in vitro models and New Approach Methodologies (NAMs) are helping researchers better understand efficacy, safety, and immune mediated responses earlier in development.

Across this free webinar series, we will explore applications spanning biologics, antibody drug conjugates, cell and gene therapies, immunotoxicity, dermatology, oncology, and regulatory toxicology, with a focus on improving translational confidence and supporting more informed decision making throughout the development process.

Our first webinar will focus on: Screening Immunotoxicity of T Cell Engagers and Biologics Using NAMs - 1 July 2026 | 3.30 PM

Key themes: T cell engagers, cytokine release syndrome, immunotoxicity, oncology.

Sign up here: https://alcyomics-ltd-144111856.hubspotpagebuilder.eu/alcyomics-webinar

For more information contact: abbas.ishaq@alcyomics.com